Steve M. Taylor; Carla Cerami; Rick M. Fairhurst,  Hemoglobinopathies: Slicing the Gordian Knot of Plasmodium falciparum Malaria Pathogenesis…

“ Malaria is an ancient disease that has persisted to our modern age, intractably killing over 500,000 children in sub-Saharan Africa each year [2] . While current interventions are succeeding in reducing its morbidity in some contexts [3] – [4] , further improvements in our fundamental understanding of the pathogenesis of Plasmodium falciparum malaria are clearly needed to identify the molecular and cellular targets of next-generation therapeutics and preventive measures. ”
Source: Wikisource

Simon I. Hay; Emelda A. Okiro; Peter W. Gething; Anand P. Patil; Andrew J. Tatem; Carlos A. Guerra; Robert W. Snow,  Estimating the Global Clinical Burden of Plasmodium falciparum Malaria in 2007…

“ Estimating the disease burden posed by malaria is an important public health challenge [1] – [2] . The clinical consequences of Plasmodium falciparum infection have several features that confound traditional approaches to disease burden and disability measurement [3] , [4] . First, not all infections result in progression to disease, notably in areas of stable transmission [5] , where populations have acquired clinical immunity [6] . ”
Source: Wikisource

Nicholas J White,  Determinants of relapse periodicity in Plasmodium vivax malaria…

“ Plasmodium vivax is a sophisticated and resilient malaria parasite which was once prevalent over much of the inhabited world. It has receded from North America, Europe and Russia, but in the tropics vivax malaria remains a major cause of childhood illness. In most endemic areas, P. vivax cohabits with Plasmodium falciparum. Mixed infections with the two species are common. P. vivax is more difficult to control and eliminate than P. falciparum because of its tendency to relapse after resolution of the primary infection. ”
Source: Wikisource

Get perspective with Kwize: daily news enlightened by great literature